Dollard des Ormeaux, Canada

Vida Gorys

This inventor holds 1 USPTO granted patent. Top assignee: Bio-mega/boehringer Ingelheim Research Inc.. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vida Gorys. Retrieved from https://idiyas.com/inventor/vida-gorys

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vida Gorys: Innovator in HIV Research

Introduction

Vida Gorys is a notable inventor based in Dollard des Ormeaux, Canada. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target HIV.

Latest Patents

Gorys holds a patent for "Substituted pyrrolidine derivatives as HIV protease inhibitors." This patent discloses compounds that inhibit the activity of human immunodeficiency virus (HIV) protease. The compounds are designed to interfere with HIV-induced cytopathogenic effects in human cells. This innovation is crucial for combating HIV infections and represents a significant advancement in antiviral therapies.

Career Highlights

Gorys is associated with Bio-Mega/Boehringer Ingelheim Research Inc., where he has been involved in groundbreaking research. His work focuses on developing effective treatments for viral infections, showcasing his commitment to improving public health.

Collaborations

Gorys has collaborated with notable colleagues, including Francedillaois Soucy and Christiane Yoakim, who contribute to the research environment at Bio-Mega/Boehringer Ingelheim Research Inc.

Conclusion

Vida Gorys is a dedicated inventor whose work in HIV research has the potential to make a significant impact on global health. His innovative compounds represent a promising avenue for the treatment of HIV infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…